Nexalin Technologies Stock Quote NXL - Stock Price, News, Charts, Message Board, Trades

Unlock more advanced trading tools

Join ADVFN today

Current Price

1.435

Bid

0.98

Ask

1.87

Volume

0.00 Day's Range 0.00

0.2528 52 Week Range 3.40

Market Cap

10.634M

Previous Close

1.435

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

881,553

Shares Outstanding

7,436,562

Dividend Yield

PE Ratio

-2.29

Earnings Per Share (EPS)

-0.63

Revenue

111k

Net Profit

-4.65M

Nexalin Technology Inc design and develop innovative neurostimulation products to uniquely and effectively help combat the ongoing global mental health epidemic. Nexalin Technology Inc design and develop innovative neurostimulation products to uniquely and effectively help combat the ongoing global mental health epidemic.

Sector

Electromedical Apparatus

Industry

Electromedical Apparatus

Website

www.nexalin.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Nexalin Technologies Inc is listed in the Electromedical Apparatus sector of the NASDAQ with ticker NXL. The last closing price for Nexalin Technologies was $1.44. Over the last year, Nexalin Technologies shares have traded in a share price range of $ 0.2528 to $ 3.40.

Nexalin Technologies currently has 7,436,562 shares outstanding. The market capitalization of Nexalin Technologies is $10.63 million. Nexalin Technologies has a price to earnings ratio (PE ratio) of -2.29.

Nexalin Technology Regains Compliance with Nasdaq Continued Listing Requirements

HOUSTON, TEXAS, April 25, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) announced that the Company received notice from The Nasdaq Stock...

Nexalin Technology Accelerates Manufacturing of its HALO™ Clarity Following Successful Usability, Feasibility, and Electrical Testing

The new Gen-3 HALO™ Clarity 15 milliamp (mA) HOUSTON, TX, April 09, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) today announced it has...

Nexalin Technology Awarded Key Patent Related to its Gen-3 HALO Clarity™, a Non-Invasive, Frequency-Based Deep-Brain Stimulation Device

HOUSTON, TX, April 04, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) today announced that the United States Patent and Trademark Office...

Nexalin Technology Announces the Appointment of Government Affairs Veteran William A. Hudson, Jr. to Military & Government Advisory Board

HOUSTON, TEXAS, April 02, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW), today announced the appointment of former Acting General Counsel to...

Nexalin Technology Announces Positive Results of Clinical Study Validating its Gen-2 tACS Device for Reducing Pain Among Veterans with Mild Traumatic Brain Injury at University of California, San Diego

Collaborative Study involving the VA and UCSD achieved statistically significant decrease in PCS and PTSD symptoms versus control group The data supports the Company’s strategy to offer military...

Nexalin Technology Commences Sales of Gen-2 Neurostimulation Device to New Mental Health Center in Oman Dedicated to Nexalin’s Technology

HOUSTON, TEXAS, March 14, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) today announced that it has commenced sales of its second generation...

Nexalin Technology Announces Poster Presentation at “State of the Technology Meeting: Neurotrauma Diagnosis, Monitoring, and Assessment”

Event hosted by the U.S. Army Medical Research and Development Command’s (USAMRDC) Combat Casualty Care Research Program (CCCRP) Neurotrauma Portfolio and the Biomedical Advanced Research and...

Nexalin Technology Announces Regulatory Approval in Oman for Gen-2 Neurostimulation Device

HOUSTON, TEXAS, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) today announced that its second generation (Gen-2), 15 milliamp (mA...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.005	0.34965034965	1.43	1.71	1.41	128886	1.56373067	CS
4	-1.045	-42.1370967742	2.48	2.89	0.791	223672	1.87436061	CS
12	1.1474	398.956884562	0.2876	3.4	0.2528	881553	1.45030914	CS
26	1.118	352.681388013	0.317	3.4	0.2528	439523	1.38502514	CS
52	0.645	81.6455696203	0.79	3.4	0.2528	234807	1.33283063	CS
156	-1.265	-46.8518518519	2.7	3.4	0.2528	210302	1.3847327	CS
260	-1.265	-46.8518518519	2.7	3.4	0.2528	210302	1.3847327	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
PRFTPerficient Inc	$ 73.97 (53.75%)	16.72k
NUVOHoldco Nuvo Group DG Ltd	$ 2.76 (35.29%)	506.78k
BENFBeneficient	$ 8.81 (29.18%)	1.07M
ASURAsure Software Inc	$ 9.00 (27.84%)	1
OMHOhmyhome Ltd	$ 0.7145 (26.68%)	1.03M
AFIBAcutus Medical Inc	$ 0.09 (-37.80%)	95.86k
MMATMeta Materials Inc	$ 2.35 (-29.85%)	9.9k
NBSENeuBase Therapeutics Inc	$ 0.3324 (-17.93%)	3.85k
WRNTWarrantee Inc	$ 0.25 (-16.11%)	1.96k
MPAAMotorcar Parts and Associates Inc	$ 4.90 (-13.12%)	1
FFIEFaraday Future Intelligent Electric Inc	$ 0.046 (12.47%)	1.47M
BENFBeneficient	$ 8.81 (29.18%)	1.07M
OMHOhmyhome Ltd	$ 0.7145 (26.68%)	1.03M
PEGYPineapple Energy Inc	$ 0.052 (-0.76%)	715.28k
JAGXJaguar Health Inc	$ 0.3189 (0.28%)	660.48k